10:55 AM EST, 02/14/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly lower late Friday morning, down 0.23% to 1,399.64 on the S&P Europe Select ADR Index. Despite the decline, the index is still up about 1% for the week.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and financial services company ING Groep ( ING ) , which rose 5.4% and 1.7% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and pharmaceutical company Ascendis Pharma ( ASND ) , which were up 1.6% and 1.4% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Genfit ( GNFT ) and argenx (ARGX), which fell 5.5% and 2% respectively. They were followed by biotech company BioNTech (BNTX) and telecommunications operator Telefonica ( TEF ) , which dropped 1.8% and 1.4% respectively.

From the UK and Ireland, the gainers were led by biotech company Autolus Therapeutics ( AUTL ) and pharmaceutical company Silence Therapeutics ( SLN ) , which increased 6.2% and 5.8% respectively. They were followed by biopharmaceutical companies NuCana ( NCNA ) and Verona Pharma ( VRNA ) , which advanced 2.8% and 2.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Biodexa Pharmaceuticals ( BDRX ) , which lost 17% and 4.2% respectively. They were followed by tobacco company British American Tobacco ( BTI ) and software development company Endava ( DAVA ) , which were down 1.5% and 1.4% respectively.